Search the Newsreel

O'Reilly Automotive, Inc. (NASDAQ:ORLY) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

O'Reilly Automotive, Inc. (NASDAQ:ORLY) has received a consensus "Moderate Buy" rating from nineteen brokerages, with an average 12-month price target of $108.44. The company recently reported strong Q2 2026 results, exceeding revenue expectations with $4.89 billion and matching EPS estimates of $0.86. Despite several …

[SCHEDULE 13D/A] Scully Royalty Ltd. Amended Major Shareholder Report

This amended Schedule 13D filing for Scully Royalty Ltd. (SRL) details a potential 48.5% voting coalition involving Peter Kellogg, Charles Kellogg, and MILFAM, aiming to influence control of the company and replace its board and management. The filing outlines the beneficial ownership of various …

Beyond the Mag 7: Rising Q3 Estimates Signal a Market-Wide Earnings Expansion

We are past the halfway mark of the Q2 earnings season, with more than 60% of S&P 500 companies having already reported. With another 27% of the index on deck this week, we will have seen the bulk of Q2 earnings by Friday. While …

Dow Jones Futures: Market Rebounds, Now Watch For This; SpaceX, AMD, Sandisk, Eli Lilly Earnings Loom

The stock market bounced but hasn't taken this step while a key risk is growing. SpaceX, AMD, Sandisk, Eli Lilly earnings loom. Continue Reading

Sam's Town Shreveport to temporarily close Friday night for Bally's ownership transition

Sam's Town Hotel and Casino in downtown Shreveport will temporarily close on Friday at 10 p.m. for an ownership transition from Boyd Gaming to Bally's Corporation. The facility is expected to reopen by Saturday afternoon under the new name Bally's Shreveport North, bringing neighboring …

Scully Royalty Ltd (SRL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Scully Royalty Ltd (SRL), noting its current valuation score of 9.90, which ranks it highly within the Metals & Mining industry. It highlights the company's P/E ratio of -5.26 and mentions that relevant P/B, P/S, and P/CF …

Quantinno Capital Management LP Has $41.44 Million Stock Position in Ally Financial Inc. $ALLY

Quantinno Capital Management LP significantly increased its stake in Ally Financial Inc. by 48.7% in the first quarter of 2026, now holding over 1 million shares valued at $41.44 million. Institutional investors collectively own 88.76% of the company. Ally Financial reported a 9.8% year-over-year …

O’Reilly Automotive Ordered to Defend Tobacco Penalty Lawsuit

O'Reilly Automotive Inc. has been ordered to defend a proposed class action lawsuit brought by a former employee. The lawsuit challenges the company's practice of charging tobacco-using workers an additional $780 annually for healthcare coverage. The employee alleges O'Reilly violated federal law by not …

Sally Beauty faces earnings test as online shift pressures retail

Sally Beauty Holdings Inc. is set to report its third-quarter fiscal 2026 results, with investors keenly watching for sustained margin gains amid increasing pressure from online sales. Analysts expect earnings of $0.54 per share on revenues of $947.5 million, reflecting sequential improvements. The company's …

Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Wall Street analysts expect Eli Lilly (LLY) to post quarterly earnings of $6.71 per share in its upcoming report, which indicates a year-over-year increase of 6.3%. Revenues are expected to be $20.26 billion, up 30.2% from the year-ago quarter. Over the past 30 days, …

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this drugmaker have returned -4.9% over the …

Do you qualify for the O'Reilly Automotive $18.8 million unsolicited text messages class action settlement?

O'Reilly Automotive has agreed to an $18.8 million settlement in a class action lawsuit over unsolicited text messages. Individuals who received two or more texts from O'Reilly Automotive after their phone number was reassigned and was on the Do Not Call Registry may be …

Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure

Round brings total capital raised to over $240 Million. BOSTON, July 31, 2026 /PRNewswire/ -- Ratio Therapeutics, Inc. (Ratio), a clinical-stage pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment, today announced the closing of a $70 million Series C financing.Ratio Therapeutics The financing included …

Roth Capital Adjusts Price Target on O'Reilly Automotive to $111 From $109, Maintains Buy Rating

Roth Capital has increased its price target for O'Reilly Automotive (ORLY) to $111 from $109, while reiterating a Buy rating on the stock. This adjustment reflects a continued positive outlook from the firm on the automotive parts distributor. Other analysts have also recently updated …

Sally Beauty Holdings, Inc. $SBH Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership reduced its stake in Sally Beauty Holdings, Inc. (NYSE:SBH) by 25.1% in the first quarter, selling 373,794 shares and now owning 1.17% of the company's stock. Other institutional investors showed mixed activity, with some increasing and others decreasing their positions. …

Dimensional Fund Advisors LP Increases Stock Holdings in Sally Beauty Holdings, Inc. $SBH

Dimensional Fund Advisors LP increased its stake in Sally Beauty Holdings, Inc. (NYSE:SBH) by 3.6% in the first quarter, now owning 6.05% of the company worth $81.32 million. Other institutional investors also adjusted their positions. Analysts have a mixed view on Sally Beauty, with …

Entropy Technologies LP Reduces Stock Position in Ally Financial Inc. $ALLY

Entropy Technologies LP significantly reduced its stake in Ally Financial Inc. by 84.5% in the first quarter, selling 39,940 shares and retaining 7,334 shares valued at approximately $288,000. Despite this, institutional investors collectively own 88.76% of Ally's stock. The company reported a 9.8% year-over-year …

Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.

This blockbuster class of drugs is shattering all sales records. Which stock will do better—Eli Lilly or Novo Nordisk? Continue Reading

Rallybio Corp (RLYB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Rallybio Corp (RLYB), noting its current valuation score of 6.53 within the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -11.68 and indicates that relevant data for P/B, P/S, and P/CF ratios have …

Is O'Reilly Automotive (ORLY) Undervalued After Its Earnings Update And Buyback Completion?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. O'Reilly Automotive (ORLY) is back in focus after its latest quarterly report and guidance update, alongside a substantial share repurchase that completed a long …

O'Reilly Auto Parts Can't Dodge Tobacco Surcharge Suit

O'Reilly Automotive Inc. is facing a lawsuit from a former employee who alleges he was unlawfully charged higher health insurance premiums due to his tobacco use. The Missouri federal court has ruled that the auto parts company must face this suit, which claims hundreds …

Rallybio Q1 2026 Earnings: Wider-than-Expected Loss as Development Costs Persist - Geographic Revenue Trends

Lilly Boosts Diabetes and Obesity Capacity With $750 Million Deal

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) and contract manufacturer Resilience will invest $750 million to expand pharmaceutical production in the Cincinnati region, adding Lilly's KwikPen injectable device to Resilience's operations. Lilly shares are down 2.24% intraday. The expansion creates at least …

Earnings call transcript: O’Reilly Automotive posts solid Q2 2026 sales, stock falls

O’Reilly Automotive (ORLY) reported Q2 2026 diluted EPS of $0.86, matching estimates, and revenue of $4.89 billion, slightly exceeding forecasts. Despite solid comparable-store sales growth of 6% and raised full-year guidance, the stock fell 2.71% due to investor focus on cautious guidance and ongoing …

O'Reilly Automotive's profits grow in Q2

O'Reilly Automotive reported a net income of $715.1 million in the second quarter. The article indicates that the detailed information is exclusively available to subscribers. It highlights the company's Q2 profit growth.

O'Reilly Q2 Earnings Beat on Strong Comparable and Pro Sales

O'Reilly Automotive, Inc. ORLY reported second-quarter 2026 earnings of 86 cents per share, up 10.3% year over year. The figure beat the Zacks Consensus Estimate of 85 cents by 1.2%. Revenues increased 8.1% to $4.89 billion and surpassed the consensus mark of $4.86 billion …

D.A. Davidson reiterates Buy on O’Reilly Automotive stock on strong comps

D.A. Davidson reiterated a Buy rating and $114.00 price target for O’Reilly Automotive (NASDAQ:ORLY) after the company reported strong second-quarter fiscal 2026 results. The auto parts retailer exceeded consensus expectations with a 6% comparable sales increase and raised its guidance for comparable sales and …

Eli Lilly and Co Stock (LLY) Moved Down by 4.09% on Jul 30: Key Drivers Unveiled

Eli Lilly and Co (LLY) stock experienced a 4.09% decline on July 30, driven by profit-taking, increasing competitive pressure in the weight-loss market from rival GLP-1 candidates, and regulatory concerns over Medicare price negotiations impacting large-cap pharmaceutical stocks. Technical factors like broken moving averages …

Eli Lilly (LLY) Joins Illumina’s Billion Cell Atlas For AI Drug Discovery

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Eli Lilly (NYSE:LLY) has joined Illumina's Billion Cell Atlas alliance as a foundational participant. …

Lilly, Resilience to invest $750 million in US drug manufacturing expansion

Eli Lilly and contract manufacturer Resilience are investing $750 million to expand pharmaceutical manufacturing capacity in the U.S. and bolster the domestic medicine supply chain. This investment will create 400 new jobs in Cincinnati, Ohio, and include the production of Lilly's KwikPen injectable device. …

Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock

Jim Cramer expressed his positive view on Eli Lilly (NYSE: LLY), calling it a "good company" he intends to hold for years due to its strong business and drugs. However, he stated he doesn't "really care for" Rigetti Computing, Inc (NASDAQ: RGTI), despite its …

Lilly, Resilience commit $750M to boost US diabetes, obesity med production

Eli Lilly and CDMO Resilience are investing $750 million to expand production of Lilly's KwikPen injectable device, used for its diabetes and obesity medications like Mounjaro and Zepbound. This investment will upgrade Resilience's Ohio facility, creating 400 new jobs and aiming for full KwikPen …

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly's KwikPen® injectable device for diabetes and obesity medicines to meet growing patient demand 400 new high-skilled jobs to be created in the Cincinnati, Ohio region Coincides …

Kelly Services (KELYA) to Post Earnings on Thursday

Gold's cooling off, but the bull case isn't broken, says The Royal Mint's Stuart O'Reilly

The Royal Mint private wealth consultant Stuart O'Reilly tells Proactive's Stephen Gunnion that gold's core drivers remain firmly in place even after its pullback from record highs, citing geopolitical tensions, shifting global alliances, and sustained central bank buying since Russia's invasion of Ukraine. Central …

Eli Lilly taps local manufacturer to boost obesity and diabetes meds

Eli Lilly and drug manufacturer Resilience are investing $750 million to expand Resilience's Blue Ash operations in Greater Cincinnati, aiming to significantly boost the production of KwikPens for Eli Lilly's popular diabetes and obesity medications like Mounjaro and Zepbound. This expansion is expected to …